NHS Dentistry: Recovery and Reform

Debate between Victoria Atkins and Andrew Lewer

Wednesday 7th February 2024 Commons Chamber

[Victoria Atkins]

The hon. Gentleman was obviously asleep at the beginning of my statement, because I set out what I hope is a fact agreed across the House about the pandemic—the real problem. People who had a relationship with a dentist before the pandemic do not face quite the same pressures as people who may have moved home or whose dentist may have moved practice. That is the cohort of people who we are trying to help. It really would help if Labour Members focused their arguments a little more on the facts, rather than on the scripts that their Whips have given out.

[Andrew Lewer (Northampton South) (Con)]

I very much welcome this statement and the meetings I have had with my neighbour, the Under-Secretary of State for Health and Social Care, my right hon. Friend the Member for South Northamptonshire (Dame Andrea Leadsom). The Secretary of State said that Northamptonshire will be included in a dental van roll-out, which is welcome, but the rest of the statement had a very rural focus. She will recall that my Prime Minister’s question focused on shortage in Duston. Is it at least a possibility that vans will go to suburban areas as well as rural ones?

[Victoria Atkins]

The criteria that will apply to the areas covered by vans are clearly set on dental need and other factors such as distance from an NHS dental practice. We have been able to identify areas of particular need, where we want to get that help as quickly as we can through the dental van initiative and the other ways detailed in the plan.

Oral Answers to Questions

Debate between Victoria Atkins and Andrew Lewer

Tuesday 23rd January 2024 Commons Chamber

[Andrew Lewer (Northampton South) (Con)]

T7. What steps is the Minister taking to ascertain the cause of ongoing problems affecting access to riluzole, the only licensed drug for the treatment of motor neurone disease in the UK, to provide clarity to the MND community and ensure that normal supply is restored as soon as possible?

[Victoria Atkins]

We understand how worrying the possibility of medication shortages can be. There is a supply issue with riluzole 50 mg tablets, caused by a supplier experiencing manufacturing issues. We have a well-established procedure in place to deal with such issues, and are working with the industry, the NHS and others to resolve it as quickly as possible. We have contacted alternative suppliers and have secured sufficient volumes of stock.